Mentice AB (publ) (STO:MNTC)

Sweden flag Sweden · Delayed Price · Currency is SEK
22.90
0.00 (0.00%)
Mar 24, 2025, 3:22 PM CET
-27.76%
Market Cap 582.97M
Revenue (ttm) 291.81M
Net Income (ttm) -18.42M
Shares Out 25.57M
EPS (ttm) -0.72
PE Ratio n/a
Forward PE 49.30
Dividend n/a
Ex-Dividend Date n/a
Volume 2,610
Average Volume 4,869
Open 22.70
Previous Close 22.90
Day's Range 22.70 - 22.90
52-Week Range 20.00 - 40.00
Beta 1.03
RSI 54.66
Earnings Date Apr 17, 2025

About Mentice AB

Mentice AB (publ) provides endovascular simulation technology solutions in Europe, the Middle East, Africa, Asia, the Asia Pacific region, and the Americas. The company operates through three segments: Systems, Software Licenses and Service. It offers software modules in the areas of acute ischemic stroke intervention, atrial septal defect and patent foramen ovale occlusion, aortic valve implantation, endovascular aortic repair, below-the-knee intervention, carotid intervention, patient-specific simulation, coronary advanced, essential, and int... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1998
Employees 132
Stock Exchange Nasdaq Stockholm
Ticker Symbol MNTC
Full Company Profile

Financial Performance

In 2024, Mentice AB's revenue was 291.81 million, an increase of 6.07% compared to the previous year's 275.12 million. Losses were -18.42 million, 553.9% more than in 2023.

Financial Statements

News

There is no news available yet.